{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:11:08Z","timestamp":1790809868095,"version":"4.1.0"},"reference-count":99,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T00:00:00Z","timestamp":1666742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cancer is a predominant cause of mortality all over the world. Lung, prostate, and colorectal cancer are the more frequent in men while breast and colorectal have a high incidence in women. Major progress aside, some cancers are still frequent and one major issue is improvements in detection methods. Imaging techniques have a major role, but inflammatory, tumoral markers and calculated scores may contribute to the assessment of prognosis. The erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and carcinoembryonic antigen cell adhesion molecule (CEACAM) have been used for decades and do not have a clear use for diagnosis or prognosis yet. The CEACAM family includes 12 human members, and some of them have a cluster differentiation (CD). CD66 may be an interesting indicator of disease severity. Beside interleukin-6 (IL-6), the high level of which is observed in patients with a high mortality rate, other cytokines IL-17A, IL-22, and transforming growth factor -\u03b2 (TGF-\u03b2) are expressed at the tumor level. The detection of circulating tumor cells has been improved but is still of undetermined value. Circulating tumor DNA (ctDNA) was recently studied in CRC stage II patients and may be helpful for chemotherapy management.<\/jats:p>","DOI":"10.3390\/ijms232112968","type":"journal-article","created":{"date-parts":[[2022,10,26]],"date-time":"2022-10-26T09:59:37Z","timestamp":1666778377000},"page":"12968","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Old and New Blood Markers in Human Colorectal Cancer"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6826-2312","authenticated-orcid":false,"given":"Jean-Luc","family":"Wautier","sequence":"first","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Denis Diderot Paris, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Paule","family":"Wautier","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Denis Diderot Paris, 75013 Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/283139a0","article-title":"The pathogenesis of cancer metastasis","volume":"283","author":"Poste","year":"1980","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ctrv.2007.08.001","article-title":"Novel cytotoxic drugs: Old challenges, new solutions","volume":"34","author":"Ismael","year":"2008","journal-title":"Cancer Treat. Rev."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s11033-018-4427-x","article-title":"Monoclonal antibodies in cancer immunotherapy","volume":"45","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3389\/fimmu.2019.02120","article-title":"Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis","volume":"10","author":"Laubli","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13304-016-0359-y","article-title":"Worldwide burden of colorectal cancer: A review","volume":"68","author":"Favoriti","year":"2016","journal-title":"Updates Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2174\/18735592MTEx9NTk2y","article-title":"Colorectal Cancer Epidemiology: Recent Trends and Impact on Outcomes","volume":"22","author":"Baidoun","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1136\/gutjnl-2019-319511","article-title":"Global patterns and trends in colorectal cancer incidence in young adults","volume":"68","author":"Siegel","year":"2019","journal-title":"Gut"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000353915","article-title":"Acidic pH of tumor microenvironment enhances cytotoxicity of the disulfiram\/Cu2+ complex to breast and colon cancer cells","volume":"59","author":"Navratilova","year":"2013","journal-title":"Chemotherapy"},{"key":"ref_12","first-page":"138","article-title":"Colorectal cancer extracellular acidosis decreases immune cell killing and is partially ameliorated by pH-modulating agents that modify tumor cell cytokine profiles","volume":"12","author":"Huntington","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-019-1331-z","article-title":"The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma","volume":"14","author":"Park","year":"2019","journal-title":"Radiat. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-2257.2003.00492.x","article-title":"The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma","volume":"25","author":"Alexandrakis","year":"2003","journal-title":"Clin. Lab. Haematol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-114-5-361","article-title":"Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group","volume":"114","author":"Friedman","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"595835","DOI":"10.3389\/fimmu.2020.595835","article-title":"C-Reactive Protein and Cancer-Diagnostic and Therapeutic Insights","volume":"11","author":"Hart","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma","volume":"20","author":"Cesana","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/cncr.28018","article-title":"Optimization of the systemic inflammation-based Glasgow prognostic score: A Glasgow Inflammation Outcome Study","volume":"119","author":"Proctor","year":"2013","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: A decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_20","first-page":"3613","article-title":"Comparison of colorectal neoplastic polyps and adenocarcinoma with regard to NLR and PLR","volume":"19","author":"Emir","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/jso.24523","article-title":"The prognostic value of neutrophil-to-lymphocyte ratio in colorectal cancer: A systematic review","volume":"115","author":"Haram","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/bjc.2013.785","article-title":"The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer","volume":"110","author":"Stotz","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Shibutani, M., Maeda, K., Nagahara, H., Ohtani, H., Iseki, Y., Ikeya, T., Sugano, K., and Hirakawa, K. (2015). The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1537-x"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00384-019-03274-6","article-title":"Systemic inflammatory response predicts oncological outcomes in patients undergoing elective surgery for mismatch repair-deficient colorectal cancer","volume":"34","author":"Climent","year":"2019","journal-title":"Int. J. Colorectal. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Zhong, B., Lin, Z.Y., Ma, D.D., Shang, Z.H., Shen, Y.B., Zhang, T., Zhang, J.X., and Jin, W.D. (2022). A preoperative prediction model based on Lymphocyte-C-reactive protein ratio predicts postoperative anastomotic leakage in patients with colorectal carcinoma: A retrospective study. BMC Surg., 22.","DOI":"10.1186\/s12893-022-01734-5"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e3837","DOI":"10.1097\/MD.0000000000003837","article-title":"Prognostic role of platelet-lymphocyte ratio in colorectal cancer: A systematic review and meta-analysis","volume":"95","author":"Tan","year":"2016","journal-title":"Medicine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijsu.2018.05.030","article-title":"Prognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis","volume":"55","author":"Tan","year":"2018","journal-title":"Int. J. Surg."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clcc.2017.03.015","article-title":"Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer?","volume":"16","author":"Rossi","year":"2017","journal-title":"Clin. Colorectal. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.7150\/ijbs.4614","article-title":"Interleukin-6--a key regulator of colorectal cancer development","volume":"8","author":"Waldner","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_31","first-page":"2832","article-title":"IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: Requirement of STAT1 protein for up-regulation of Fas and FasL expression","volume":"58","author":"Xu","year":"1998","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/scbi.2000.0314","article-title":"Immune-inflammatory mechanisms in IFNgamma-mediated anti-tumor activity","volume":"10","author":"Tannenbaum","year":"2000","journal-title":"Semin. Cancer Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.20020063","article-title":"Suppression of lymphoma and epithelial malignancies effected by interferon gamma","volume":"196","author":"Street","year":"2002","journal-title":"J. Exp. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1158\/0008-5472.CAN-11-1316","article-title":"Prognostic and predictive impact of intra- and peritumoral immune infiltrates","volume":"71","author":"Fridman","year":"2011","journal-title":"Cancer Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1158\/0008-5472.CAN-10-2907","article-title":"Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer","volume":"71","author":"Tosolini","year":"2011","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1038\/onc.2014.286","article-title":"Th17-type cytokines, IL-6 and TNF-alpha synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth","volume":"34","author":"Franze","year":"2015","journal-title":"Oncogene"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/BF02361238","article-title":"Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis","volume":"29","author":"Ueda","year":"1994","journal-title":"J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"16334","DOI":"10.3748\/wjg.v20.i43.16334","article-title":"Diagnostic value of interleukin-8 in colorectal cancer: A case-control study and meta-analysis","volume":"20","author":"Jin","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.canlet.2014.08.021","article-title":"Interleukin-8 promotes cell migration through integrin alphavbeta6 upregulation in colorectal cancer","volume":"354","author":"Sun","year":"2014","journal-title":"Cancer Lett."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Xia, W., Chen, W., Zhang, Z., Wu, D., Wu, P., Chen, Z., Li, C., and Huang, J. (2015). Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: A meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0123484"},{"key":"ref_41","first-page":"713","article-title":"Predictive value of IL-18 and IL-10 in the prognosis of patients with colorectal cancer","volume":"18","author":"Li","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"964","DOI":"10.7150\/ijbs.4564","article-title":"Complexities of TGF-beta targeted cancer therapy","volume":"8","author":"Connolly","year":"2012","journal-title":"Int. J. Biol. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1383-5742(03)00033-4","article-title":"Molecular aspects of epithelial cell plasticity: Implications for local tumor invasion and metastasis","volume":"566","author":"Gotzmann","year":"2004","journal-title":"Mutat. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI80007","article-title":"Immunity, inflammation, and cancer: An eternal fight between good and evil","volume":"125","author":"Shalapour","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200408028","article-title":"Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP","volume":"167","author":"Sabeh","year":"2004","journal-title":"J. Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Wautier, J.L., and Wautier, M.P. (2022). Vascular Permeability in Diseases. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23073645"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1084\/jem.121.3.439","article-title":"Demonstration of Tumor-Specific Antigens in Human Colonic Carcinomata by Immunological Tolerance and Absorption Techniques","volume":"121","author":"Gold","year":"1965","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10555-013-9444-6","article-title":"Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis","volume":"32","author":"Beauchemin","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0006-291X(90)90866-L","article-title":"Nonspecific cross-reacting antigen (NCA) expressed by human granulocytes: Six species with different peptide sizes and membrane anchoring forms","volume":"166","author":"Kuroki","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1158\/0008-5472.CAN-04-4140","article-title":"Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin","volume":"65","author":"Aarnoudse","year":"2005","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygeno.2013.07.003","article-title":"Gene conversions are under purifying selection in the carcinoembryonic antigen immunoglobulin gene families of primates","volume":"102","author":"Zid","year":"2013","journal-title":"Genomics"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/excr.1999.4610","article-title":"Redefined nomenclature for members of the carcinoembryonic antigen family","volume":"252","author":"Beauchemin","year":"1999","journal-title":"Exp. Cell Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1083\/jcb.200204041","article-title":"Distinct molecular and cellular contributions to stabilizing selectin-mediated rolling under flow","volume":"158","author":"Yago","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/glycob\/cwx105","article-title":"Selectins in cancer immunity","volume":"28","author":"Borsig","year":"2018","journal-title":"Glycobiology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e98664","DOI":"10.15252\/embj.201798664","article-title":"The Helicobacter pylori adhesin protein HopQ exploits the dimer interface of human CEACAMs to facilitate translocation of the oncoprotein CagA","volume":"37","author":"Bonsor","year":"2018","journal-title":"EMBO J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.3389\/fimmu.2019.03160","article-title":"CEACAM3-A Prim(at)e Invention for Opsonin-Independent Phagocytosis of Bacteria","volume":"10","author":"Bonsignore","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_57","first-page":"3419","article-title":"Human carcinoembryonic antigen functions as a general inhibitor of anoikis","volume":"60","author":"Ordonez","year":"2000","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1158\/0008-5472.CAN-06-4315","article-title":"Carcinoembryonic antigen inhibits anoikis in colorectal carcinoma cells by interfering with TRAIL-R2 (DR5) signaling","volume":"67","author":"Samara","year":"2007","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1073\/pnas.1005842108","article-title":"Carcinoembryonic antigen-related cell adhesion molecule 16 interacts with alpha-tectorin and is mutated in autosomal dominant hearing loss (DFNA4)","volume":"108","author":"Zheng","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ceb.2006.08.008","article-title":"CEACAMs: Their role in physiology and pathophysiology","volume":"18","author":"Kuespert","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1479-5876-6-78","article-title":"Interdependency of CEACAM-1, -3, -6, and -8 induced human neutrophil adhesion to endothelial cells","volume":"6","author":"Skubitz","year":"2008","journal-title":"J. Transl. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines","volume":"39","author":"Hastings","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1084\/jem.20030437","article-title":"Specific regulation of T helper cell 1-mediated murine colitis by CEACAM1","volume":"199","author":"Iijima","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.intimp.2016.12.024","article-title":"Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients","volume":"43","author":"Zhang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4049\/jimmunol.1801625","article-title":"A Deficit of CEACAM-1-Expressing T Lymphocytes Supports Inflammation in Primary Progressive Multiple Sclerosis","volume":"203","author":"Piancone","year":"2019","journal-title":"J. Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3393\/ac.2019.11.13","article-title":"A Review of the Role of Carcinoembryonic Antigen in Clinical Practice","volume":"35","author":"Hall","year":"2019","journal-title":"Ann. Coloproctol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s10620-011-1606-1","article-title":"Should a colonoscopy be recommended for healthy individuals with increased carcinoembryonic antigen levels? A case-control study","volume":"56","author":"Lee","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/annonc\/mdw222","article-title":"CEA response is associated with tumor response and survival in patients with KRAS exon 2 wild-type and extended RAS wild-type metastatic colorectal cancer receiving first-line FOLFIRI plus cetuximab or bevacizumab (FIRE-3 trial)","volume":"27","author":"Michl","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3233\/CBM-150561","article-title":"The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients","volume":"16","author":"Pakdel","year":"2016","journal-title":"Cancer Biomark"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/abbi.1996.0440","article-title":"Processing of carcinoembryonic antigen by Kupffer cells: Recognition of a penta-peptide sequence","volume":"334","author":"Gangopadhyay","year":"1996","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Wautier, J.L., and Wautier, M.P. (2021). Endothelial Cell Participation in Inflammatory Reaction. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126341"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"10744","DOI":"10.1073\/pnas.90.22.10744","article-title":"Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas","volume":"90","author":"Neumaier","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","first-page":"4938","article-title":"The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is down-regulated in malignant mouse tissues","volume":"53","author":"Rosenberg","year":"1993","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cca.2012.09.003","article-title":"Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer","volume":"415","author":"Kim","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.sla.0000154455.86404.e9","article-title":"CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions","volume":"241","author":"Duxbury","year":"2005","journal-title":"Ann. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"32924","DOI":"10.1016\/S0021-9258(20)30079-X","article-title":"CGM2, a member of the carcinoembryonic antigen gene family is down-regulated in colorectal carcinomas","volume":"269","author":"Thompson","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.surg.2009.10.056","article-title":"CEACAM-7: A predictive marker for rectal cancer recurrence","volume":"147","author":"Messick","year":"2010","journal-title":"Surgery"},{"key":"ref_78","first-page":"5043","article-title":"Four targeted genes for predicting the prognosis of colorectal cancer: A bioinformatics analysis case","volume":"18","author":"Bian","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.clcc.2014.09.004","article-title":"CA 19-9 as a marker in addition to CEA to monitor colorectal cancer","volume":"13","author":"Stiksma","year":"2014","journal-title":"Clin. Colorectal. Cancer"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1515\/cclm-2012-0744","article-title":"CA 19-9: Handle with care","volume":"51","author":"Galli","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_81","first-page":"2141","article-title":"TAG-72 expression and its role in the biological evaluation of human colorectal cancer","volume":"16","author":"Guadagni","year":"1996","journal-title":"Anticancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"731350","DOI":"10.3389\/fonc.2021.731350","article-title":"Survival Advantage Following TAG-72 Antigen-Directed Cancer Surgery in Patients With Colorectal Carcinoma: Proposed Mechanisms of Action","volume":"11","author":"Hitchcock","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"4310790","DOI":"10.1155\/2018\/4310790","article-title":"Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer","volume":"2018","author":"Wang","year":"2018","journal-title":"Dis. Markers"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1515\/CCLM.2003.098","article-title":"Hematopoietic growth factors in colorectal cancer patients","volume":"41","author":"Mroczko","year":"2003","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1074\/mcp.M800596-MCP200","article-title":"Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays","volume":"8","author":"Babel","year":"2009","journal-title":"Mol. Cell Proteomics"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1158\/0008-5472.CAN-07-0649","article-title":"Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers","volume":"67","author":"Leman","year":"2007","journal-title":"Cancer Res."},{"key":"ref_87","first-page":"156","article-title":"Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer","volume":"8","author":"Christensen","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/cancers6010366","article-title":"The role of matrix metalloproteinases in colorectal cancer","volume":"6","author":"Said","year":"2014","journal-title":"Cancers"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/bjc.2015.88","article-title":"Circulating tumour cells and outcome in non-metastatic colorectal cancer: A prospective study","volume":"112","author":"Bork","year":"2015","journal-title":"Br. J. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","article-title":"Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer","volume":"26","author":"Cohen","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/1878-0261.12507","article-title":"Detection of circulating tumor cells in colorectal cancer patients using the GILUPI CellCollector: Results from a prospective, single-center study","volume":"13","author":"Dizdar","year":"2019","journal-title":"Mol. Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1586\/14737159.2016.1123095","article-title":"Challenges for CTC-based liquid biopsies: Low CTC frequency and diagnostic leukapheresis as a potential solution","volume":"16","author":"Stoecklein","year":"2016","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/ijc.26232","article-title":"Candidate microRNA biomarkers in human colorectal cancer: Systematic review profiling studies and experimental validation","volume":"130","author":"Ma","year":"2012","journal-title":"Int. J. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: Genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/gm477","article-title":"Circulating tumor cells and DNA as liquid biopsies","volume":"5","author":"Heitzer","year":"2013","journal-title":"Genome Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.surg.2011.08.013","article-title":"CpG island methylator phenotype infers a poor disease-free survival in locally advanced rectal cancer","volume":"151","author":"Jo","year":"2012","journal-title":"Surgery"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11912-021-01022-0","article-title":"Targeting KRAS in Colorectal Cancer","volume":"23","author":"Wang","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0959-8049(02)00811-0","article-title":"Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines","volume":"39","author":"Duffy","year":"2003","journal-title":"Eur. J. Cancer"},{"key":"ref_99","first-page":"760","article-title":"Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply","volume":"387","author":"Tie","year":"2022","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12968\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:03:26Z","timestamp":1760144606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/21\/12968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,26]]},"references-count":99,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijms232112968"],"URL":"https:\/\/doi.org\/10.3390\/ijms232112968","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,26]]}}}